ZACCARO, LAURA
 Distribuzione geografica
Continente #
AS - Asia 2.307
NA - Nord America 1.518
EU - Europa 565
SA - Sud America 429
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 38
OC - Oceania 1
Totale 4.991
Nazione #
US - Stati Uniti d'America 1.410
SG - Singapore 943
CN - Cina 542
BR - Brasile 337
VN - Vietnam 261
HK - Hong Kong 213
IT - Italia 193
FR - Francia 154
KR - Corea 95
BD - Bangladesh 60
CA - Canada 48
JP - Giappone 46
IN - India 45
GB - Regno Unito 38
DE - Germania 37
NL - Olanda 34
FI - Finlandia 30
AR - Argentina 22
MX - Messico 22
ID - Indonesia 21
CO - Colombia 18
PL - Polonia 16
EC - Ecuador 15
IL - Israele 13
ZA - Sudafrica 13
CR - Costa Rica 10
SA - Arabia Saudita 10
TR - Turchia 10
VE - Venezuela 10
CL - Cile 9
RU - Federazione Russa 9
PH - Filippine 8
JM - Giamaica 7
PY - Paraguay 7
UA - Ucraina 7
ES - Italia 6
IQ - Iraq 6
NI - Nicaragua 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
EG - Egitto 5
GR - Grecia 5
MY - Malesia 5
NP - Nepal 5
BO - Bolivia 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KE - Kenya 3
LT - Lituania 3
PK - Pakistan 3
SC - Seychelles 3
SE - Svezia 3
BG - Bulgaria 2
BZ - Belize 2
DZ - Algeria 2
GA - Gabon 2
GP - Guadalupe 2
HN - Honduras 2
IE - Irlanda 2
IR - Iran 2
LB - Libano 2
MA - Marocco 2
MK - Macedonia 2
MU - Mauritius 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
Totale 4.858
Città #
Singapore 546
Santa Clara 321
Hong Kong 213
Hefei 209
San Jose 189
Beijing 116
Lauterbourg 114
Ashburn 105
Ho Chi Minh City 101
Seoul 95
Dallas 55
Los Angeles 52
Hanoi 50
Naples 36
Tokyo 33
São Paulo 31
New York 24
Frankfurt am Main 21
Montreal 19
Buffalo 18
Rio de Janeiro 17
Da Nang 15
Helsinki 15
Casandrino 13
Lappeenranta 13
Warsaw 13
Afragola 12
Chennai 12
Minamishinagawa 12
Phoenix 12
Rome 12
Atlanta 11
Council Bluffs 11
Milan 11
Bengaluru 10
Chicago 10
Guangzhou 9
Haiphong 9
Orem 9
Philadelphia 9
Brooklyn 8
Ercolano 8
The Bronx 8
Amsterdam 7
Cavallino 7
Charlotte 7
Cincinnati 7
Dhaka 7
Manchester 7
Belo Horizonte 6
Bogotá 6
Haikou 6
Hải Dương 6
Las Vegas 6
Lima 6
Managua 6
Miami 6
San José 6
Thái Bình 6
Athens 5
Boston 5
Can Tho 5
Curitiba 5
Denver 5
Elk Grove Village 5
Guarulhos 5
Guayaquil 5
Houston 5
Jeddah 5
Nuremberg 5
Porto Alegre 5
Richmond 5
Salvador 5
Toronto 5
Ankara 4
Aracaju 4
Baltimore 4
Brasília 4
Caserta 4
Jackson 4
Johannesburg 4
Juiz de Fora 4
Kathmandu 4
London 4
Marília 4
Mexico City 4
Orlando 4
Pittsburgh 4
Poplar 4
Quito 4
Quận Một 4
Riyadh 4
Santiago 4
Seattle 4
São José dos Campos 4
Turin 4
Vienna 4
Auburn 3
Baghdad 3
Bandung 3
Totale 2.885
Nome #
18FLUORO-ACTIVE PEPITDES.: OPTIMIZATION OF RADIOLABELLING SYNTHESIS 86
Therapeutic Potential of a Novel alpha(v)beta(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type 85
Peptoids: Smart and Emerging Candidates for the Diagnosis of Cancer, Neurological and Autoimmune Disorders 83
Gold-Speckled SPION@SiO2 Nanoparticles Decorated with Thiocarbohydrates for ASGPR1 Targeting: Towards HCC Dual Mode Imaging Potential Applications 83
Molecular interactions between a diphenyl scaffold and PED/PEA15: Implications for type II diabetes therapeutics targeting PED/PEA15 - Phospholipase D1 interaction 77
Isolation, Characterization and IgE Binding of Two 2S Albumins of Pomegranate Seeds 76
Conformational studies of RGDechi peptide by natural-abundance NMR spectroscopy 73
NIR Emitting Nanoprobes Based on Cyclic RGD Motif Conjugated PbS Quantum Dots for Integrin-Targeted Optical Bioimaging 73
Purification and Characterization of Punein, a Pomegranate PR-4 Protein Showing Structural Similarities with the Hevein Precursor 73
A new cryptic host defense peptide identified in human 11-hydroxysteroid dehydrogenase-1 ?-like: from in silico identification to experimental evidence 72
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alpha v beta (3) Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies. 67
A multi-targeting approach to fight sars-cov-2 attachment 65
Sistemi modello per lo studio del sito catalitico di Metallo-Enzimi 63
Design, synthesis and characterization of a peptide able to bind proteins of the KCTD family: implications for KCTD-cullin 3 recognition 63
An overview of peptide-based molecules as potential drug candidates for multiple sclerosis 63
Investigation of the Best Conditions to Obtain c(RGDfK) Peptide on Solid Phase 62
Substitution of the Native Zn(II) with Cd(II), Co(II) and Ni(II) Changes the Downhill Unfolding Mechanism of Ros87 to a Completely Different Scenario 62
Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development 61
Selective Detection of alfa_v beta_3 Integrin Receptors Using [99mTc(N)PNP]-labelled RGDechi Peptides 61
High-Resolution Conformational Analysis of RGDechi-Derived Peptides Based on a Combination of NMR Spectroscopy and MD Simulations 61
A novel approach for studying receptor-ligand interactions on living cells surface by using NUS/T1ρ-NMR methodologies combined with computational techniques: The RGDechi15D-αvβ5 integrin complex 60
A selective ?v?5 integrin antagonist hidden into the anophelin family protein cE5 from the malaria vector anopheles gambiae 60
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 59
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 58
The Arabidopsis SUPERMAN protein is able to specifically bind DNA through its single Cys2-His2 zinc finger motif 53
Synthetic peptides mimicking the interleukin-6/gp130 interaction: A two-helix bundle system. Design and confirmational studies 53
Gold Nanoparticles Capped by a GC-Containing Peptide Functionalized with an RGD Motif for Integrin Targeting. 51
Structural Zn(II) Implies a Switch from Fully Cooperative to Partly Downhill Folding in Highly Homologous Proteins 51
Conformational behaviour of C alpha,alpha-diphenylglycine: Folded vs. extended structures in D phi G-containing tripeptides 50
Screening a Molecular Fragment Library to Modulate the PED/PEA15-Phospholipase D1 Interaction in Cellular Lysate Environments 50
NMR structure of the single QALGGH zinc finger domain from the Arabidopsis thaliana SUPERMAN protein 50
In vitro activity of the avb3 integrin antagonist RGDechi-hCit on malignant melanoma cells 49
Selective Targeting of alphavbeta5 Integrin in HepG2 Cell Line by RGDechi15D Peptide 49
On-Bead Peptoid Dimerization Induced by Incorporation of Glycosylated Bridging Units in Submonomer Solid-Phase Approach to Glycopeptoids 48
18FLUORO-ACTIVE-PEPTIDES: OPTIMIZATION OF RADIOLABELLING SYNTHESIS 48
Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin. 48
Evaluation of the anti-angiogenic properties of the new selective alpha(V)beta(3) integrin antagonist RGDechiHCit 46
Bioinspired RGD-Functionalized Gold Nanoparticles for Integrin-Driven Interaction with Melanoma Cells 46
31st BIOMEDICAL NANOTECHNOLOGY: PREPARATION AND CHARACTERIZATION OF NEW FUNCTIONALIZED GOLD NANOPARTICLES 45
Chemical Modification for Proteolytic Stabilization of the Selective alpha(v)beta(3) Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells 45
LC-MS and MALDI-TOF supported metabolism studies of the selective ?v?3 RGDechi peptide and of thecorresponding [99mTc(N)PNP]-tagged derivatives. 44
Conjugated Platinum(II)-peptide complexes for targeting integrin receptors 43
Structure-Based Design of a Potent Artificial Transactivation Domain Based on p53 43
The prokaryotic Cys2His2 zinc finger domain adopts a novel fold as revealed by the solution structure of Agrobacterium tumefaciens Ros DNA binding domain 42
A CUL3-DERIVED PEPTIDE BINDING DIFFERENT MEMBERS OF THE KCTD FAMILY 42
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 41
Zinc to cadmium replacement in the prokaryotic zinc-finger domain 41
HIGH YIELD HPLC PURIFICATION OF 18F-RDG-ECHI FOR INJECTION INTO MICE. 40
A new Nerve Growth Factor (NGF)-mimetic peptide active on neuropathic pain in rats. 40
Heterodimeric peptide compounds displaying NGF activity and their use to treat neurodegenerative disorders 39
Synthetic peptides mimicking the interleukin-6/gp130 interaction: A two-helix bundle system. Design and conformational studies 39
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 38
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 37
In vitro activity of the alfavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells. 37
Design, synthesis and evaluation of gluten peptide analogues as inhibitors of the HLA/DQ8-mediated celiac immune response 37
Deciphering the zinc coordination properties of the prokaryotic zinc finger domain: The solution structure characterization of Ros87 H42A functional mutant 37
Silver nanoparticles functionalized with a fluorescent cyclic RGD peptide: a versatile integrin targeting platform for cells and bacteria 36
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 35
PREPARATION AND CHARACTERIZATION OF NEW FUNCTIONALIZED GOLD NANOPARTICLES 34
Insights into the anticancer properties of the first antimicrobial peptide from Archaea 34
AN IMPROVED RADIOLABELING SYNTHESIS OF RGDECHI WITH 18F-FLUORIDE. 33
Structural NMR studies of zinc finger domains 33
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 33
Imaging of alpha(v)beta(3) integrin expression with a 18F-labeled RGD peptide and microPET 33
MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide 32
P53/TFIIH complex: structure-guided design of peptides to modulate apoptosis mediated by p53-dependent pathways 32
Targeting avb3 integrin receptor by a new and selective peptide antagonist for tumour imaging and radionuclide therapy 32
A new and selective radiolabeled áVâ3 peptide antagonist as tracer in tumor diagnosis 32
The (unusual) aspartic acid in the metal coordination sphere of the prokaryotic zinc finger domain 32
BIOMEDICAL NANOTECHNOLOGY: PREPARATION AND CHARACTERIZATION OF NEW FUNCTIONALIZED GOLD NANOPARTICLES 31
Cullin3-BTB Interface: A Novel Target for Stapled Peptides 31
A RADIOLABELING SYNTHESIS OF RGD ECHI WITH 18FLUORIDE- 31
A New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 31
Zinc to Cadmium Replacement in the A. thaliana SUPERMAN Cys(2)His(2) Zinc Finger Induces Structural Rearrangements of Typical DNA Base Determinant Positions. 31
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 31
MIXED CONFORMATION IN C-ALPHA,C-ALPHA-DISUBSTITUTED TRIPEPTIDES - X-RAY CRYSTAL-STRUCTURES OF Z-AIB-DPH-GLY-OME AND BZ-DPH-DPH-GLY-OME 30
IMAGING IN VIVO DELL'ESPESSIONE DELL'INTEGRINA alfa(v)beta(3) CON UN PEPTIDE CHIMERICO RGD RADIOMARCATO 30
BB14, a Nerve Growth Factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury 30
A NEW AND SELECTIVE RADIOLABELED ALPHAVBETA3 PEPTIDE ANTAGONIST AS TRACER IN TUMOR DIAGNOSIS. 30
New high yield HPLC purification with ethanol of 18F-RGDEchi and directly injection in mice 30
Engineering peptides in angiogenesis 30
Selective avb3 receptor peptide antagonist for therapeutic and diagnostic applications 30
A STRUCTURAL 2-RING VERSION OF A TUBULAR STACK OF BETA-RINGS IN CRYSTALS OF A CYCLIC D,L-HEXAPEPTIDE 29
A Novel Type of Zinc Finger DNA Binding Domain in the Agrobacterium tumefaciens Transcriptional Regulator Ros 29
Development Of Peptides Able To Modulate The Interaction Of AKAP121 With Mitochondria 29
ASSESSMENT OF THE IN VITRO ACTIVITY OF RGDECHI-HCIT, alpha V beta3 INTEGRIN ANTAGONIST, ON MALIGNANT MELANOMA CELLS 28
Novel and selective alpha v beta 3 receptor peptide antagonist: Design, synthesis and biological behaviour 28
Rationally designed peptides acting as Nerve Growth Factor analogs and active on neuropathic pain in rats 28
Conformational behaviour of Cα,α-diphenylglycine: Folded vs. extended structures in DφG-containing tripeptides 28
Deciphering rgdechi peptide??5?1integrin interaction mode in isolated cell membranes 27
Targeting avb3 integrin receptor by a new and selective peptide antagonist 27
TRPV1 modulators: Structure-activity relationships using a rational combinatorial approach 27
Conformational features of human melanin-concentrating hormone: an NMR and computational analysis 27
Reactive astrocytosis-induced perturbation of synaptic homeostasis is restored by nerve growth factor 27
KCTD7: a new substrate-specific adaptor for Cul3 involved in Progressive Myoclonic Epilepsy 27
New and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis 26
Novel and Selective Ligand of the Integrin n Ñv Ò3 Receptor: Design, Synthesis and Biological Behaviour 26
Structure-based design of short peptides and samll molecules that compete with P53 for binding to TFIIH 26
Identification of PED binders through NMR spectroscopy 26
RGDechi-hCit: alpha v beta 3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells 26
Totale 4.386
Categoria #
all - tutte 17.991
article - articoli 11.656
book - libri 114
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202451 0 0 0 0 0 0 0 0 11 4 26 10
2024/20251.594 8 5 170 88 295 31 39 87 51 57 410 353
2025/20262.716 146 315 253 427 517 87 390 130 128 160 74 89
2026/2027630 157 136 337 0 0 0 0 0 0 0 0 0
Totale 4.991